BIOREM Inc.
BRM.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1,591.64% | -47.71% | 118.64% | -89.85% | -92.87% |
| Total Depreciation and Amortization | -31.90% | -28.95% | 44.24% | 71.61% | -30.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 82.84% | -50.74% | 77.32% | -61.03% | -193.68% |
| Change in Net Operating Assets | 136.00% | -540.87% | 0.16% | 16.62% | 55.61% |
| Cash from Operations | 300.73% | -71.15% | 30.36% | 5.57% | -4,380.85% |
| Capital Expenditure | -445.95% | -- | -6,566.67% | 76.49% | -104.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -445.95% | -- | -6,566.67% | 76.49% | -104.17% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -12.04% | 28.56% | -10.06% | 9.49% | -32.79% |
| Issuance of Common Stock | -90.12% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -576.92% | -19.88% | -8.77% | 14.98% | 127.20% |
| Foreign Exchange rate Adjustments | 83.27% | -92.32% | -332.46% | -143.60% | -150.53% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 253.64% | -79.59% | 3.73% | 14.16% | -2,095.08% |